The Latest Breaking News from 23andMe

DNA kits offer fascinating insights into your genetic background, but they might be a privacy nightmare.

23andMe, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the company’s stock hit a rock-bottom of US$0.30, down 96 per cent from its peak share price of US$17.65 in 2021.

I gave away my genetic information to a now imploding company for results that inspired nothing but ambivalence

Lippincott has been on a mission to meet as many of her new-found family members as she can

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach, several rounds of previous layoffs and piling losses that plunged the company’s stock over recent years

The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.”

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs

Company says it will cut about 200 employees as value plummets in aftermath of huge data breach

Genetic testing company 23andMe will be restructuring the company to save on costs.

V4 engines are all the rage right now. Whether it's Ducati, KTM, or Yamaha, everyone's got to have one to compete at the tippy top of the superbike spear. So it's no wonder that newcomer, but heavy-weight player, CFMoto would be not only developing a V4 platform but saving its…

The genetic testing company, once worth $6 billion, has lost most of its value.